192 related articles for article (PubMed ID: 12097583)
1. Determination of the structure of a decay accelerating factor-binding clinical isolate of echovirus 11 allows mapping of mutants with altered receptor requirements for infection.
Stuart AD; McKee TA; Williams PA; Harley C; Shen S; Stuart DI; Brown TD; Lea SM
J Virol; 2002 Aug; 76(15):7694-704. PubMed ID: 12097583
[TBL] [Abstract][Full Text] [Related]
2. Two clusters of mutations map distinct receptor-binding sites of echovirus 11 for the decay-accelerating factor (CD55) and for canyon-binding receptors.
Rezaikin AV; Novoselov AV; Sergeev AG; Fadeyev FA; Lebedev SV
Virus Res; 2009 Oct; 145(1):74-9. PubMed ID: 19540285
[TBL] [Abstract][Full Text] [Related]
3. The structure of echovirus type 12 bound to a two-domain fragment of its cellular attachment protein decay-accelerating factor (CD 55).
Bhella D; Goodfellow IG; Roversi P; Pettigrew D; Chaudhry Y; Evans DJ; Lea SM
J Biol Chem; 2004 Feb; 279(9):8325-32. PubMed ID: 14634014
[TBL] [Abstract][Full Text] [Related]
4. Interaction between echovirus 7 and its receptor, decay-accelerating factor (CD55): evidence for a secondary cellular factor in A-particle formation.
Powell RM; Ward T; Evans DJ; Almond JW
J Virol; 1997 Dec; 71(12):9306-12. PubMed ID: 9371589
[TBL] [Abstract][Full Text] [Related]
5. Interaction of decay-accelerating factor with echovirus 7.
Plevka P; Hafenstein S; Harris KG; Cifuente JO; Zhang Y; Bowman VD; Chipman PR; Bator CM; Lin F; Medof ME; Rossmann MG
J Virol; 2010 Dec; 84(24):12665-74. PubMed ID: 20881044
[TBL] [Abstract][Full Text] [Related]
6. A single amino acid substitution controls DAF-dependent phenotype of echovirus 11 in rhabdomyosarcoma cells.
Novoselov AV; Rezaykin AV; Sergeev AG; Fadeyev FA; Grigoryeva JV; Sokolova ZI
Virus Res; 2012 Jun; 166(1-2):87-96. PubMed ID: 22445689
[TBL] [Abstract][Full Text] [Related]
7. Decay-accelerating factor binding determines the entry route of echovirus 11 in polarized epithelial cells.
Sobo K; Rubbia-Brandt L; Brown TD; Stuart AD; McKee TA
J Virol; 2011 Dec; 85(23):12376-86. PubMed ID: 21917947
[TBL] [Abstract][Full Text] [Related]
8. Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate.
Milstone AM; Petrella J; Sanchez MD; Mahmud M; Whitbeck JC; Bergelson JM
J Virol; 2005 Jan; 79(1):655-60. PubMed ID: 15596863
[TBL] [Abstract][Full Text] [Related]
9. Structural and functional insights into the interaction of echoviruses and decay-accelerating factor.
Pettigrew DM; Williams DT; Kerrigan D; Evans DJ; Lea SM; Bhella D
J Biol Chem; 2006 Feb; 281(8):5169-77. PubMed ID: 16272562
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of Swine vesicular disease virus and implications for host adaptation.
Fry EE; Knowles NJ; Newman JW; Wilsden G; Rao Z; King AM; Stuart DI
J Virol; 2003 May; 77(9):5475-86. PubMed ID: 12692248
[TBL] [Abstract][Full Text] [Related]
11. Interaction of decay-accelerating factor with coxsackievirus B3.
Hafenstein S; Bowman VD; Chipman PR; Bator Kelly CM; Lin F; Medof ME; Rossmann MG
J Virol; 2007 Dec; 81(23):12927-35. PubMed ID: 17804498
[TBL] [Abstract][Full Text] [Related]
12. The crystal structure of a coxsackievirus B3-RD variant and a refined 9-angstrom cryo-electron microscopy reconstruction of the virus complexed with decay-accelerating factor (DAF) provide a new footprint of DAF on the virus surface.
Yoder JD; Cifuente JO; Pan J; Bergelson JM; Hafenstein S
J Virol; 2012 Dec; 86(23):12571-81. PubMed ID: 22973031
[TBL] [Abstract][Full Text] [Related]
13. A novel cell entry pathway for a DAF-using human enterovirus is dependent on lipid rafts.
Stuart AD; Eustace HE; McKee TA; Brown TD
J Virol; 2002 Sep; 76(18):9307-22. PubMed ID: 12186914
[TBL] [Abstract][Full Text] [Related]
14. Structure of decay-accelerating factor bound to echovirus 7: a virus-receptor complex.
He Y; Lin F; Chipman PR; Bator CM; Baker TS; Shoham M; Kuhn RJ; Medof ME; Rossmann MG
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10325-9. PubMed ID: 12119400
[TBL] [Abstract][Full Text] [Related]
15. More recent swine vesicular disease virus isolates retain binding to coxsackie-adenovirus receptor, but have lost the ability to bind human decay-accelerating factor (CD55).
Jimenez-Clavero MA; Escribano-Romero E; Ley V; Spiller OB
J Gen Virol; 2005 May; 86(Pt 5):1369-1377. PubMed ID: 15831949
[TBL] [Abstract][Full Text] [Related]
16. Attachment of coxsackievirus B3 variants to various cell lines: mapping of phenotypic differences to capsid protein VP1.
Schmidtke M; Selinka HC; Heim A; Jahn B; Tonew M; Kandolf R; Stelzner A; Zell R
Virology; 2000 Sep; 275(1):77-88. PubMed ID: 11017789
[TBL] [Abstract][Full Text] [Related]
17. Enterovirus capsid interactions with decay-accelerating factor mediate lytic cell infection.
Newcombe NG; Johansson ES; Au G; Lindberg AM; Barry RD; Shafren DR
J Virol; 2004 Feb; 78(3):1431-9. PubMed ID: 14722298
[TBL] [Abstract][Full Text] [Related]
18. Determination of the affinity and kinetic constants for the interaction between the human virus echovirus 11 and its cellular receptor, CD55.
Lea SM; Powell RM; McKee T; Evans DJ; Brown D; Stuart DI; van der Merwe PA
J Biol Chem; 1998 Nov; 273(46):30443-7. PubMed ID: 9804811
[TBL] [Abstract][Full Text] [Related]
19. Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor.
Martino TA; Petric M; Brown M; Aitken K; Gauntt CJ; Richardson CD; Chow LH; Liu PP
Virology; 1998 May; 244(2):302-14. PubMed ID: 9601501
[TBL] [Abstract][Full Text] [Related]
20. Enterovirus 70 receptor utilization is controlled by capsid residues that also regulate host range and cytopathogenicity.
Kim MS; Racaniello VR
J Virol; 2007 Aug; 81(16):8648-55. PubMed ID: 17537857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
